Cansino Biologics Inc.

04/13/2021 | Press release | Distributed by Public on 04/13/2021 04:53

VOLUNTARY ANNOUNCEMENT - ENROLLMENT OF PHASE III CLINICAL TRIAL FOR 13-VALENT PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (CRM197, TT)